Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Porter

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|December 4, 2001
RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse originsD C Ansardi, D C Porter, C A Jackson, et al.
Virology|April 7, 1998
Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferaseD C Porter, D C Ansardi, J Wang, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteinsM J Anderson, D C Porter, Z Moldoveanu, et al.
Molecular and Cellular Biology|August 18, 2001
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsD C Porter, N Zhang, C Danes, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Cancer Research|December 15, 1994
Characterization of poliovirus replicons encoding carcinoembryonic antigenD C Ansardi, Z Moldoveanu, D C Porter, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|December 4, 2001
RNA replicons derived from poliovirus are directly oncolytic for human tumor cells of diverse originsD C Ansardi, D C Porter, C A Jackson, et al.
Virology|April 7, 1998
Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferaseD C Porter, D C Ansardi, J Wang, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteinsM J Anderson, D C Porter, Z Moldoveanu, et al.
Molecular and Cellular Biology|August 18, 2001
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsD C Porter, N Zhang, C Danes, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Cancer Research|December 15, 1994
Characterization of poliovirus replicons encoding carcinoembryonic antigenD C Ansardi, Z Moldoveanu, D C Porter, et al.
Pageof 4